CD207 and nasopharyngeal carcinoma: In addition to T-cell observations, following morphological findings suggesting a presence of DCs in NPC lesions [7,8,9,10,11,12], we recently reported on intralesional DC subsets and particularly highlighted CD1c+ myeloid cells expressing the C-lectin receptor CD207 [13].